Spirulina in Clinical Practice: Evidence-Based Human Applications
2011

Spirulina in Clinical Practice: Evidence-Based Human Applications

Sample size: 41 publication Evidence: moderate

Author Information

Author(s): Karkos P. D., Leong S. C., Karkos C. D., Sivaji N., Assimakopoulos D. A.

Primary Institution: Liverpool University Hospitals

Conclusion

Spirulina is a safe food supplement with potential benefits for allergic rhinitis and cholesterol management, but more research is needed to confirm its effectiveness in other areas.

Supporting Evidence

  • Spirulina has been shown to reduce IL-4 levels by 32% in individuals with allergic rhinitis.
  • A study found that Spirulina significantly improved symptoms of allergic rhinitis compared to placebo.
  • Spirulina may help lower LDL cholesterol levels in patients with hyperlipidaemia.

Takeaway

Spirulina is a type of algae that might help with allergies and cholesterol, but we need more studies to be sure.

Methodology

The review summarizes various studies, including randomized controlled trials and systematic reviews, on the effects of Spirulina on different health conditions.

Potential Biases

Some studies may have biases due to small sample sizes or lack of randomization.

Limitations

Many studies are small, unblinded, or lack high-level evidence, making it difficult to draw definitive conclusions.

Participant Demographics

The studies included various populations, including individuals with allergic rhinitis and chronic arsenic poisoning.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.001

Digital Object Identifier (DOI)

10.1093/ecam/nen058

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication